| MAT-CHDSP, a novel medication assessment tool for evaluation of secondary prevention of coronary heart disease. | |
| | |
MedLine Citation:
|
PMID: 21351306 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: Quality of health performance is of increasing international importance. The potential value of the implementation of a guideline-based medication assessment tool (MAT) has been evaluated in order to measure and improve adherence to guideline recommendations in secondary prevention of coronary heart disease (CHD). METHOD: An existing MAT developed in the UK based on internationally recognised clinical evidence has been further developed [with criteria extended to secondary prevention of CHD only] for application in Norway. Content validity was demonstrated using a two round Delphi process among an expert group (12 reviewers, consensus threshold 75%). Inter- and intra-observer reliability testing was conducted with agreement expressed by Cohen's kappa (κ). The designed MAT was applied in a pilot study and application time was measured to inform clinical utility of the tool in real world settings. A total of 85 patients (69% male) undergoing coronary angiography were included. Mean age was 65.4 years (SD 11.6). RESULTS: The new MAT is named MAT-CHDSP and comprises 21 review criteria. Consensus among the expert group (n = 12) was obtained for all final criteria. Reliability testing showed κ in the range (0.79-0.90). Applicability in the pilot study was 63% (n = 1106) and adherence was 65%, 95% CI (64-66) (n = 791). The mean application time for the experienced user was 1.5 minutes (SD 0.3). CONCLUSION: MAT methodology might merge the increasing demand for continuous assessment of quality of health performance with the clinical pharmacist's need for a standardised and explicit working tool. Copyright © 2010 John Wiley & Sons, Ltd. |
| | |
Authors:
|
Beate Hennie Garcia; June Utnes; Liv Unni Naalsund; Trude Giverhaug |
Related Documents
:
|
19486236 - Strong inbreeding depression in male mating behaviour in a poeciliid fish. 20093816 - An approach to addressing depression in patients with chronic kidney disease. 19473406 - Is inbreeding depression lower in maladapted populations? a quantitative genetics model. 20120516 - Scars in depression: is a conceptual shift necessary to solve the puzzle? 22525956 - Neurocognitive outcomes in the treatment of early-onset schizophrenia spectrum disorder... 22528976 - Predicting clinically significant change in an inpatient program for people with severe... |
Publication Detail:
|
Type: Journal Article Date: 2010-12-23 |
Journal Detail:
|
Title: Pharmacoepidemiology and drug safety Volume: 20 ISSN: 1099-1557 ISO Abbreviation: Pharmacoepidemiol Drug Saf Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-02-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9208369 Medline TA: Pharmacoepidemiol Drug Saf Country: England |
Other Details:
|
Languages: eng Pagination: 249-57 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 John Wiley & Sons, Ltd. |
Affiliation:
|
Hospital Pharmacy of North Norway Trust, Tromsø, Norway; Department of Pharmacy, Faculty of Health Science, University of Tromsø, Tromsø, Norway. beate@unn.no. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medici...
Next Document: Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.